Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-10-31
1997-12-09
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514530, 514912, A61K 3119, A61K 31215
Patent
active
056961669
ABSTRACT:
Compositions containing a HETE derivative and methods of use for treating dry eye are disclosed.
REFERENCES:
patent: 3991759 (1976-11-01), Urquhart
patent: 4131651 (1978-12-01), Shah et al.
patent: 4370325 (1983-01-01), Packman
patent: 4409205 (1983-10-01), Shively
patent: 4744980 (1988-05-01), Holly
patent: 4818537 (1989-04-01), Guo
patent: 4883658 (1989-11-01), Holly
patent: 4906467 (1990-03-01), Schwartzman et al.
patent: 4914088 (1990-04-01), Glonek et al.
patent: 4966773 (1990-10-01), Gressel et al.
patent: 5041434 (1991-08-01), Lubkin
patent: 5075104 (1991-12-01), Gressel et al.
patent: 5290572 (1994-03-01), MacKeen
patent: 5294607 (1994-03-01), Glonek et al.
patent: 5358706 (1994-10-01), Marlin et al.
patent: 5389383 (1995-02-01), Huth
patent: 5403598 (1995-04-01), Beck et al.
patent: 5403841 (1995-04-01), Lang et al.
Graeber et al. "15-Hydroxyeicosatetraenoic Acid Stimulates Migration Of Human Retinal Microvessel Endothelium In Vitro And Neovascularization In Vivo", Prostaglandins, vol. 39, No. 6, pp. 665-673 (1990).
Masferrer et al., "12(R)-Hydroxyeicosatetraenoic Acid, An Endogenous Corneal Arachidonate Metabolite, Lowers Intraocular Pressure In Rabbits", Investigative Ophthalmology And Visual Science, vol. 31, No. 3, pp. 535-539 (1990).
Wiggins, et al., "12(S)-Hydroxy-5,8,10,14-Eicosatetraenoic Acid Is A More Potent Neutrophil Chemoattractant Than The 12(R) Epimer In The Rat Cornea", Prostaglandins, vol. 40, No. 2, pp. 131-141 (1990).
Yanni, et al. Effect of Intravenously Administered Lipoxygenase Metabolites on Rat Trachael Mucous Gel Layer Thickness, International Archives of Allergy And Applied Immunology, vol. 90, pp. 307-309 (1989).
Johnson, et al., 15-Hydroxyeicosatetraenoic Acid is a Potent Inflammatory Mediator and Agonist of Canine Tracheal Mucus Secretion, From the Hypersensitivity Diseases Research, Lipids Research, The Upjohn Company, Kalamazoo, Michigan, pp. 917-922 (1984).
Watanabe, et al., Human Corneal and Conjuctival Epithelia Produce a Mucin-like Glycoprotein for the Apical Surface, Investigative Ophthalmology and Visual Science, vol. 36, No. 2, pp. 337-344 (1995).
Greiner, et al, Mucus Secretory Vesicles in Conjunctival Epithelial Cells of Wearers of Contact Lenses, Archives of Ophthalmology, vol. 98, pp. 1843-1846 (1980).
Dilly, et al., Surface changes in the anaesthetic conjunctiva in man, with special reference to the production of mucus from a non-goblet-cell source, British Journal of Ophthalmology, vol. 65, pp. 833-842 (1981).
Shelhamer, et al., The Effects of Arachinoids and Leukotrienes on the Release of Mucus from Human Airways, Chest Supplement, 24th Aspen Lung Conference, vol. 81, No. 5, pp. 36S-37S (1982).
Yanni, et al, Effect of Intravenously Administered Lipoxygenase Metabolites on Rat Trachael Mucous Gel Layer Thickness, International Archives of Allergy And Applied Immunology, vol. 90, pp. 307-309 (1989).
Marom et al., Human Airway Monohydroxyeicosatetraenoic Acid Generation and Mucus Release, Journal of Clinical Investigation, vol. 72, pp. 122-127 (1983).
Graff et al., Activation of Soluble Splenic Cell Guanylate Cyclase by Prostaglandin Endoperoxides and Fatty Acid Hydroperoxides, Journal of Biological Chemistry, vol. 253, No. 21, pp. 7662-7676 (1978).
Graff, Preparation of 15-L-Hydroperoxy-5,8,11,13-eicosatetraenoic Acid 915-HPETE), Methods in Enzymology, vol. 86, pp. 386-392 (1982).
Corey et al., 12-Hydroxy-5,8,14-(Z)-10-(E)-eicosatetraeonoic Acid (12-HETE), The Logic of Chemical Synthesis, John Wiley and Sons, sections 12.9 and 12.11 (1989).
Marom et al., Effects of Arachidonic Acid, Monohydroxyeicosatetraenoic Acid and Prostaglandins on the Release of Mucous Glycoproteins from Human Airways In Vitro, The Journal of Clinical Investigation, vol. 67, pp. 1695-1702 (1981).
Hamberg et al., Identification of 15-hydroxy-5,8,11,13-eicosatetraenoic acid (15-HETE) as a major metabolite of arachidonic acid in human lung, Acta Physiol Scand, vol. 110, pp. 219-221 (1980).
Dohlman, Symposium On The Dry Eye, New Concepts In Ocular Xerosis, Ophthalmological Societies Of The United Kingdom, vol. XCI, pp. 105-118 (1971).
Lemp, Tear Substitutes in the Treatment of Dry Eyes, External Ocular Diseases: Diagnosis And Current Therapy, Laibson and Trobe (ed.), Little, Brown and Company, Boston, vol. 13, No. 4, pp. 145-153 (1973).
Lemp, Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes, CLAO Journal vol. 21, No. 4, pp. 221-231 (1995).
Gamache Daniel A.
Miller Steven T.
Yanni John M.
Fay Zohreh
Mayo Michael C.
LandOfFree
Compositions containing hydroxyeicosatetraenoic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions containing hydroxyeicosatetraenoic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions containing hydroxyeicosatetraenoic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1608229